2020
A Statewide Assessment of Antifungal Stewardship Activities in Acute-Care Hospitals in Connecticut
Bromberg R, Leung V, Maloney M, Paranandi A, Banach D. A Statewide Assessment of Antifungal Stewardship Activities in Acute-Care Hospitals in Connecticut. Infection Control And Hospital Epidemiology 2020, 41: s105-s105. DOI: 10.1017/ice.2020.609.Peer-Reviewed Original ResearchAcute care hospitalsInfectious disease consultationCandida bloodstream isolatesDisease consultationAntifungal susceptibility testingAntifungal therapyBloodstream isolatesConnecticut hospitalsCandidemia treatmentSusceptibility testingInstitutional guidelinesAntibiotic stewardship principlesCandida bloodstream infectionsDays of therapyEmpiric antifungal therapyInfectious disease physiciansInvasive fungal infectionsCDC core elementsAntifungal expenditureAntifungal utilizationOral conversionDisease physiciansHospitalized patientsProspective auditBloodstream infections
2018
2411. Expanded Susceptibility and Resistance Mechanism Testing Among Carbapenem-Resistant Enterobacteriaceae in Connecticut, 2017
Durante A, Maloney M, Leung V, Macierowski B, Noel D, Razeq J, Banach D. 2411. Expanded Susceptibility and Resistance Mechanism Testing Among Carbapenem-Resistant Enterobacteriaceae in Connecticut, 2017. Open Forum Infectious Diseases 2018, 5: s721-s721. PMCID: PMC6253689, DOI: 10.1093/ofid/ofy210.2064.Peer-Reviewed Original ResearchState public health laboratoriesLaboratory Standards Institute breakpointsPolymerase chain reaction testingReal-time polymerase chain reaction testingCeftazidime/avibactamCarbapenem-resistant EnterobacteriaceaePublic health laboratoriesCRE isolatesEmpiric treatmentCP-CRECarbapenemase testingReaction testingHealth laboratoriesCarbapenemase productionCarbapenem inactivation methodSusceptibility testingCommon carbapenemasesBroth microdilutionNon-CPDisk diffusionInactivation methodCreAntibiogramClinicalAvibactam